Loading organizations...
§ Private Profile · Newton, MA, USA
Biopharmaceutical company developing cancer-targeting therapies.
Siamab Therapeutics has raised $2.0M across 1 funding round.
Siamab Therapeutics has raised $2.0M in total across 1 funding round.
Siamab Therapeutics has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Series B Extension in July 2014.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 14, 2014 | $2M Series B Plus | — | Beacon Angels, Boston Harbor Angels, Desert Angels, Launchpad Venture Group, Maine Angels, Mass Medical Angels | Announced |
Siamab Therapeutics has raised $2.0M in total across 1 funding round.
Siamab Therapeutics's investors include Beacon Angels, Boston Harbor Angels, Desert Angels, Launchpad Venture Group, Maine Angels, Mass Medical Angels.